Top Story

Four regulatory news updates in ophthalmology

November 28, 2014

From late October through November, notable regulatory decisions were made by the U.S. Food and Drug Administration, Centers for Medicare and Medicaid Services and the Irish Health Products Regulatory Authority – from recommendations to approve a multifocal toric IOL to positive reimbursement statuses for implants and injections.

Ocular Surgery News spotlights four regulatory decisions made that ophthalmologists should know to better treat patients who require such procedures.

thumbnail for video 3907892114001 Meeting News CoverageVideo

VIDEO: Wound closure with new technologies

November 26, 2014
NEW YORK — At OSN New York, John A. Hovanesian, MD, discusses corneal wounds, leak rates and the challenges associated with wound closure and the use of hydrogel…

Iluvien earns marketing authorization in Ireland

November 26, 2014
Alimera Sciences announced that marketing authorization has been granted to Iluvien in Ireland.Through the repeat use application procedure, the Irish Health Products…
Blog

BLOG: Build a diverse team to see results

November 26, 2014
A close-up look at diversity: What is it? Why does it matter? Diversity is a word that has been batted around for years. In past decades, the emphasis on diversity was…
In the Journals

Cost, insurance authorization affect decision making in treatment of uveitis

November 26, 2014
Among uveitis and retina specialists, cost, insurance prior authorization, pregnancy considerations and subspecialty practice were factors affecting therapeutic…
More News Headlines »
Original Article

Combining Automated Vision Screening With On-site Examinations in 23 Schools: ReFocus on Children Program 2012 to 2013

Journal of Pediatric Ophthalmology and Strabismus
Online Advanced Release, December 1, 2014
The Association for the Blind and Visually Impaired (ABVI) began the ReFocus on Children Program to assist school…
More »
CME
j477

Rapid Response: Real World Use of Anti-VEGF Therapy - Clinical Experience Beyond Pivotal Trials

This activity is supported by an educational grant from Genentech, Inc.

Management of retinal vascular diseases with anti-VEGF therapy has been well-established through large-scale trials…
More »
Meeting News Coverage Video
thumbnail for video 3903624648001

VIDEO: Pearls on dealing with refractive surprises

November 23, 2014
NEW YORK — At the OSN New York meeting here, Larry Berstein, MD, discusses the best way to avoid refractive…
More »
morganatic-roan